Prognosis and Patient-Reported Outcomes of Combined Local Treatments (Radiotherapy and Surgery or Radiotherapy Alone) with Almonertinib and Chemotherapy in EGFR-Mutant Stage III-N3 Non-Small Cell Lung Cancer: A Prospective, Single-Center, Phase II Trial
/ Not yet recruitingNot ApplicableIIT A Prospective, Multicenter, Randomized Controlled Study of Three-dimensional Visualization Techniques to Improve the Quality and Safety of Robot-assisted Nephron Sparing Surgery for Complex Renal Tumors
The goal of this clinical trial is to learn the evidence-based medical value of 3D visualization techniques to improve tumor control, preservation of renal function, and perioperative safety in robot-assisted nephron sparing surgery for complex renal tumors. The main question it aims to answer is:
Is 3D visualization techniques more effective in improving robot-assisted nephron sparing surgery for complex renal tumors in terms of tumor control, renal function preservation, and perioperative safety.
The researchers will randomize participants into a 3D trial group and a conventional group for comparison.
Participants will:
Complete Blood routine, liver and kidney function tests on the first and third day after operation.
Have Renography at 3 and 12 months after the operation. Cooperate with follow-up visits.
A Single-Center, Open-Label, Phase II Study of Tislelizumab + SOX Regimen as a New Adjuvant Long-Course Treatment for Locally Advanced Gastric Cancer/Gastric Cardia Adenocarcinoma
100 Clinical Results associated with Liaoning Tumor Hospital & Institute
0 Patents (Medical) associated with Liaoning Tumor Hospital & Institute
100 Deals associated with Liaoning Tumor Hospital & Institute
100 Translational Medicine associated with Liaoning Tumor Hospital & Institute